RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
15.20
+1.06 (7.50%)
Sep 11, 2025, 10:50 AM - Market open
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $251.37 million as of September 11, 2025. Its market cap has increased by 209.10% in one year.
Market Cap
251.37M
Enterprise Value
68.06M
1-Year Change
209.10%
Ranking
Category
Stock Price
$15.20
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has decreased from $276.64M to $251.37M, a decrease of -9.13%. That is a compound annual growth rate of -1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 233.84M | 9.67% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |